Investing Profile

Julie Grant

VCInvestor

General Partner at Canaan

canaan.com/team/julie-grantSan Francisco Bay Area

Your Intro Paths to Julie Grant

Signal uses Gmail to reveal intro paths. Email content is never read.

Networks Julie is a member of

Moving Capital Network

963 CONNECTIONS

Goldman Sachs Network

890 CONNECTIONS

Yale University Network

365 CONNECTIONS

University of Cambridge Network

324 CONNECTIONS

Genentech Network

67 CONNECTIONS

Find Julie Grant on

Current Investing Position

Canaan Partners General Partner

Investment Range

$250K - $20.0M

Sweet Spot

$10.0M

Investments On Record

Current Fund Size

$800M

Julie Grant is on these Sector & Stage Rankings

Pharmaceuticals (Seed)BioTech (Seed)BioTech (Series A)Health IT (Series A)Diverse Investors Pharmaceuticals (Series A)Female Investors Health & Hospital Services (Series A)Consumer Internet (Seed)San Francisco Bay Area Consumer Internet (Series A)Health IT (Seed)Health & Hospital Services (Seed)

Julie Grant's Investments On Record (5)

Company	StageDateRound Size	Total Raised
Vedana Therapeutics	Series AJun 2026$46M	$46M
Co-investors: Mira Chaurushiya (Westlake Village BioPartners)
Nocion Therapeutics	Series BJan 2026$23M Series AApr 2019$27M	$50M
Synthekine	Series BJun 2021$110M Series ASep 2020$82M	$290M
Co-investors: Tim Kutzkey (The Column Group)
Day One Biopharmaceuticals	Series BFeb 2021$130M Series AMay 2020$60M	$370M
Co-investors: Dan Becker (Access Industries), Michael Gladstone (Atlas Venture), Derek DiRocco (RA Capital Management)
Protagonist Therapeutics	Series CJul 2015$40M	$54M
Co-investors: Asish Xavier (Johnson & Johnson Innovation)

Julie Grant's Experience

Summer Analyst, Americas Special Situations Group Goldman SachsPresent

Licensing Intern Yale UniversityPresent

Business Development Intern GenentechPresent

BioOncology Project Manager GenentechPresent

Market Planning Manager - Tarceva GenentechPresent

Market Planning Manager - BioOncology New Products Lead GenentechPresent

Board Observer LABRYS BIOLOGICS, INC.Present

Associate CanaanPresent

Board Observer Dermira, Inc.Present

Board Observer ALDEA PharmaPresent

Board Observer CytomX TherapeuticsPresent

Seed Investor and Board Observer Cellular ResearchPresent

Board Observer Moving CapitalPresent

Principal CanaanPresent

Board Observer GlookoPresent

Board Member Protagonist TherapeuticsPresent

Board Member Biden Cancer InitiativePresent

Board Member Nocion Therapeutics, Inc.Present

Board Member SynthekinePresent

Chair Of The Board Of Directors Day One BiopharmaceuticalsPresent

Partner CanaanPresent

Co-Founder and Chief Executive Officer Day One BiopharmaceuticalsPresent

General Partner CanaanPresent

Julie Grant's Education

Yale University B.S. Molecular Biophysics and biochemistry

University of Cambridge MPhil BioScience Enterprise

Investors who invest with Julie Grant

Scouts & Angels Affiliated With Julie Grant